Stakeholders Give Opposing Views On GIs In EU-US Trade Agreement 12/02/2015 by William New, Intellectual Property Watch Leave a Comment Geographical indications – product names deriving from geographical origin or certain characteristics – are increasingly on the table when trade negotiations include Europeans, who are trying to recover names long used around the world. In a recent stakeholder event for the Transatlantic Trade and Investment Partnership (TTIP), both sides of the GI issue made their case.
UK Defence Science And Tech Lab To Offer IP Royalty-Free Licences 11/02/2015 by William New, Intellectual Property Watch Leave a Comment The Defence Science and Technology Laboratory (Dstl) has announced it will participate in a plan for sharing some of its intellectual property for research royalty-free, making it the first United Kingdom government agency to do so.
Copyright Policy And The Right To Science And Culture 09/02/2015 by Intellectual Property Watch 2 Comments Reposted from Afro-IP and infojustice.org: A report entitled ‘Copyright policy and the right to science and culture’ authored by the UN Special Rapporteur in the field of cultural rights, Farida Shaheed, has been released, writes Prof. Carolyn Ncube.
ANEPI IP News: Tres Cerveceros Y Una Marca (Three Brewers And A Brand) 09/02/2015 by Intellectual Property Watch, Intellectual Property Watch Leave a Comment Welcome to (ANEPI), the first Intellectual Property News Agency of Ecuador. The Agencia de Noticias Especializada en Propiedad Intelectual (ANEPI) publishes news, analysis, interviews, feature articles, a weekly update and more on Ecuador and the region, at http://www.anepi.ec. Articles are primarily in Spanish with some translation. Bienvenido a (ANEPI), La Primera Agencia de Noticias de […]
US Challenges For Biotech In 2015 – An Interview With BIO’s Hans Sauer 06/02/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment The biotechnology industry is closely watching developments in the United States that could impact the industry in 2015. These include the regulatory framework for biosimilars, possible patent legislation, post-grant review procedure, and the consequences of the recent Supreme Court ruling banning the patenting of human genes. Hans Sauer, Deputy General Counsel for Intellectual Property at the Biotechnology Industry Organization (BIO), recently spoke with Intellectual Property Watch’s Catherine Saez. Sauer was asked to lay out the main developments to watch in the coming year.
South Africa Supreme Court Of Appeal Losing Its Shape 05/02/2015 by Intellectual Property Watch Leave a Comment South Africa’s Supreme Court of Appeal has been blessed for the past few decades by having in its ranks judges who have experience and expertise in the field of Intellectual Property Law, writes law professor Owen Dean. With the recent retirement of Louis Harms, the bench at the Supreme Court of Appeal has been denuded of judges who can be regarded as IP experts. The paucity of IP experience on the bench is regrettably beginning to show. In recent times the Supreme Court of Appeal has given three IP judgments in trade mark cases which, it is respectfully submitted, have been wrongly decided and are not in harmony with the principles of trade mark law and practice, Dean argues.
Unlimited Potential: The Innovation Renaissance Is Now 05/02/2015 by Intellectual Property Watch, Intellectual Property Watch 2 Comments By Patrick Kilbride At no other time in history has humanity enjoyed such a boundless period of innovation. The human experience is literally changing day-to-day as new medicines and new technologies create solutions to seemingly insurmountable global challenges such as poverty, hunger, disease, and climate change. This 21st century innovation renaissance could not be more […]
Questions About Funding, Text Of Tufts Study On Drug Costs 03/02/2015 by Intellectual Property Watch Leave a Comment The Union for Affordable Cancer Treatment has sent a letter to the author of a much-noted Tufts University (US) study that found high development costs for medicines, with copies to the university administration. The letter requests transparency on the funding of the study and the press conference announcing the results, as well as copies of the study itself, which the group says was not made public, along with details to justify the result.
The Latest News In Intellectual Property From ANEPI Ecuador 02/02/2015 by Intellectual Property Watch, Intellectual Property Watch Leave a Comment Welcome to (ANEPI), the first Intellectual Property News Agency of Ecuador. The Agencia de Noticias Especializada en Propiedad Intelectual (ANEPI) publishes news, analysis, interviews, feature articles, a weekly update and more on Ecuador and the region, at http://www.anepi.ec. Articles are primarily in Spanish with some translation. Bienvenido a (ANEPI), La Primera Agencia de Noticias de […]
Circuit Courts Open As Satellites Of China’s Supreme People’s Court 01/02/2015 by Mingjiang Liu for Intellectual Property Watch Leave a Comment After long preparations, the Second Circuit Court of China’s Supreme People’s Court was officially instituted in Shenyang city, Liaoning province in northeast China on 31 January. Qiang Zhou, president and chief judge of China’s Supreme People’s Court, attended and addressed the nameplate unveiling ceremony of the Second Circuit Court.